Reporter
VUMC awarded CDC funding to combat antimicrobial resistance, infectious diseases
Dec. 7, 2021—Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).
Potential Rett syndrome drug shows promising results in phase 3 trial
Dec. 6, 2021—A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.
VUMC mourns loss of pediatric immunology expert Lawton
Dec. 6, 2021—Alexander R. “Sandy” Lawton III, MD, emeritus professor of Pediatrics, died earlier this fall at 82.
VKC data shows increase in autism spectrum disorder prevalence, provides new data on 4-year-olds
Dec. 2, 2021—Vanderbilt Kennedy Center (VKC) researchers are seeing an increase in the number of children in Tennessee with autism spectrum disorder (ASD).
Gene discoveries give new hope to people who stutter
Dec. 2, 2021—New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter.
Surveys show VUMC patients value immediate online access to test results
Dec. 2, 2021— by Paul Govern Vanderbilt University Medical Center patients are overwhelmingly in favor of having immediate electronic access to their clinical test results, recent surveys show. A federal rule in effect since April 5 was designed in part to ensure that patients are given electronic access to their health information upon their request and at no cost, including, with very few exceptions,...
Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms
Dec. 2, 2021— by Bill Snyder The global biopharmaceutical company AstraZeneca announced more good news about its long-acting combination of two monoclonal antibodies against COVID-19 that were discovered at Vanderbilt University Medical Center. In a prevention trial, one prophylactic, intramuscular injection of the antibody combination, called AZD7442, reduced the risk of symptoms occurring after exposure to the...
Directorships honor VUMC leaders and philanthropic partners
Dec. 2, 2021—Ten Vanderbilt University Medical Center leaders from across the enterprise in clinical care, research, education and administration have been named as holders of endowed directorships.
Thyroid cancer paper lands national recognition
Dec. 2, 2021—by Tom Wilemon A group of investigators in the Endocrine Neoplasia Research Laboratory at Vanderbilt University Medical Center has received national recognition for their work to discover better treatments for thyroid cancer. A paper describing their lab work was awarded first place in the Basic Science category at the 2021 Cancer Research Competition, which promotes...
VUMC celebrates 20th anniversary of custom-built EHR
Dec. 2, 2021—Vanderbilt University Medical Center recently commemorated the 20th anniversary of StarPanel, the first fully integrated electronic health record (EHR) in use in a major health system and developed independent of a vendor.
Study links depression scores, white blood cell count
Dec. 2, 2021— by Emily Stembridge Researchers across four health care systems, including Vanderbilt University Medical Center, have found that increased depression polygenic scores are associated with increased white blood cell count, highlighting the importance of the immune system in the etiology of depression. Despite a wide understanding of depression as a psychiatric disorder, depression’s underlying biological...
Reid selected for clinical trial development program
Dec. 2, 2021—Vanderbilt's Sonya Reid, MD, MPH, has been selected to participate in the first cohort of the Bristol Myers Squibb Foundation Clinical Trial Diversity Career Development Program.
